Institutional Ownership Autolus Therapeutics PLC (AUTL)
This table provides information about the institutional ownership of Autolus Therapeutics PLC (AUTL). We have compiled data on the 103 institutions that hold shares in the stock, with a total of 150 Million shares, which have been reported (via 13F filing form) to have a value of $208 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Mak Capital One LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
26,017,616
shares
|
$36.2 Million
6.54% of portfolio
|
Q3 2025
Added 53.45%
|
|
|
Blackstone Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
20,485,611
shares
|
$28.5 Million
0.15% of portfolio
|
Q4 2022
Added 13.9%
|
|
|
Syncona Portfolio LTD
Guernsey, Channel Islands, X0 |
Nov 06, 2025 Q3 2025 |
16,640,720
shares
|
$23.1 Million
97.83% of portfolio
|
Q4 2024
Reduced 10.31%
|
|
|
Armistice Capital, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
15,600,000
shares
|
$21.7 Million
0.39% of portfolio
|
Q3 2025
Added 30.0%
|
|
|
Tfg Asset Management Gp LTD
Grand Cayman, E9 |
Nov 14, 2025 Q3 2025 |
9,500,000
shares
|
$13.2 Million
3.44% of portfolio
|
Q2 2025
Added 10.47%
|
|
|
Schroder Investment Management Group
London, X0 |
Nov 12, 2025 Q3 2025 |
8,433,253
shares
|
$11.7 Million
0.01% of portfolio
|
Q3 2025
Added 133.71%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
6,044,243
shares
|
$8.4 Million
0.0% of portfolio
|
Q3 2025
Added 501.79%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2025 Q3 2025 |
4,881,372
shares
|
$6.79 Million
0.01% of portfolio
|
Q3 2025
Added 178.74%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 14, 2025 Q3 2025 |
4,623,324
shares
|
$6.43 Million
0.32% of portfolio
|
Q1 2024
Added 23.39%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,436,102
shares
|
$6.17 Million
0.0% of portfolio
|
Q2 2024
Added 9.37%
|
|
|
Axa Investment Managers S.A.
Puteaux, I0 |
Nov 14, 2025 Q3 2025 |
3,361,156
shares
|
$4.67 Million
0.02% of portfolio
|
Q3 2025
New holding
|
|
|
Laurion Capital Management LP
New York, NY |
Nov 14, 2025 Q3 2025 |
3,316,626
shares
|
$4.61 Million
0.1% of portfolio
|
Q2 2025
Reduced 1.56%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
2,568,613
shares
|
$3.57 Million
0.13% of portfolio
|
Q3 2025
Reduced 84.76%
|
|
|
Odey Asset Management Group LTD
London, X0 |
May 15, 2023 Q1 2023 |
2,499,400
shares
|
$3.47 Million
1.52% of portfolio
|
Q4 2022
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
2,029,593
shares
|
$2.82 Million
0.0% of portfolio
|
Q3 2025
Added 108.13%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 13, 2025 Q3 2025 |
1,853,422
shares
|
$2.58 Million
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Affinity Asset Advisors, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
1,750,000
shares
|
$2.43 Million
0.33% of portfolio
|
Q3 2025
Reduced 42.53%
|
|
|
Pendal Group LTD
|
Jan 19, 2023 Q4 2022 |
1,733,391
shares
|
$2.41 Million
0.03% of portfolio
|
Q4 2022
Added 26.46%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
1,213,773
shares
|
$1.69 Million
0.0% of portfolio
|
Q3 2025
Added 162.38%
|
|
|
Health Invest Partners Ab
|
Nov 04, 2025 Q3 2025 |
1,169,634
shares
|
$1.63 Million
0.83% of portfolio
|
Q3 2025
Added 5.81%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
903,068
shares
|
$1.26 Million
0.0% of portfolio
|
Q3 2025
Reduced 35.96%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
874,474
shares
|
$1.22 Million
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Cetera Investment Advisers
Schaumburg, IL |
Nov 14, 2025 Q3 2025 |
801,250
shares
|
$1.11 Million
0.0% of portfolio
|
Q3 2025
Added 29.83%
|
|
|
Alphabet Inc.
Mountain View, CA |
Nov 06, 2025 Q3 2025 |
698,262
shares
|
$970,584
0.07% of portfolio
|
Q2 2020
Reduced 0.16%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 13, 2025 Q3 2025 |
641,952
shares
|
$892,313
0.0% of portfolio
|
Q3 2025
New holding
|
|